SCOPUS 정보 검색 플랫폼

Volumn 75, Issue 3, 2001, Pages 184-188

Tamoxifen-induced Ca2+ mobilization in bladder female transitional carcinoma cells

(9) Chang, Hong Tai a Huang, Jong Khing a Wang, Jue Long a Cheng, Jin Shiung a Lee, Kam Chung a Lo, Yuk Keung a Lin, Muh Chiou a Tang, Kwong Yui a Jan, Chung Ren a,b

a KAOHSIUNG VETERANS GENERAL HOSPITAL (Taiwan)

b NATIONAL SUN YAT SEN UNIVERSITY (Taiwan)

Author keywords

BFTC cells; Bladder cell carcinoma; Ca2+ signaling; Fura 2; Tamoxifen

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FURA 2; INOSITOL 1,4,5 TRISPHOSPHATE; NIFEDIPINE; PHOSPHOLIPASE C; TAMOXIFEN; THAPSIGARGIN; VERAPAMIL; 1 (6 ((3 METHOXYESTRA 1,3,5(10) TRIEN 17 YL)AMINO)HEXYL) 1H PYRROLE 2,5 DIONE; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 PYRROLIDONE DERIVATIVE; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; ESTRANE DERIVATIVE; FLUORESCENT DYE;

ARTICLE; BLADDER CARCINOMA; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; BLADDER TUMOR; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

ANTICARCINOGENIC AGENTS; CALCIUM SIGNALING; CARCINOMA, TRANSITIONAL CELL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRENES; FLUORESCENT DYES; FURA-2; HUMANS; PHOSPHOLIPASE C; PYRROLIDINONES; TAMOXIFEN; THAPSIGARGIN; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0035345112 PISSN: 03405761 EISSN: None Source Type: Journal
DOI: 10.1007/s002040100212 Document Type: Article

Times cited : (12)

References (20)

1
- 0027397544
- Inositol trisphosphate and calcium signaling
- Berridge MJ (1993) Inositol trisphosphate and calcium signaling. Nature 361:315-325
- (1993) Nature , vol.361 , pp. 315-325
- Berridge, M.J.¹

2
- 0030932943
- Elementary and global aspects of calcium signaling
- Berridge MJ (1997) Elementary and global aspects of calcium signaling. J Physiol 499:291-306
- (1997) J Physiol , vol.499 , pp. 291-306
- Berridge, M.J.¹

3
- 0033866203
- Chemoprevention of breast cancer
- Brown PH, Lippman SM (2000) Chemoprevention of breast cancer. Breast Cancer Res Treat 62:1-17
- (2000) Breast Cancer Res Treat , vol.62 , pp. 1-17
- Brown, P.H.¹ Lippman, S.M.²

4
- 0028831997
- Calcium signaling
- Clapham DE (1995) Calcium signaling. Cell 80:259-268
- (1995) Cell , vol.80 , pp. 259-268
- Clapham, D.E.¹

5
- 0028034083
- The antitumor agent tamoxifen inhibits breakdown of polyphosphoinositides in GH4C1 cells
- Friedman ZY (1994) The antitumor agent tamoxifen inhibits breakdown of polyphosphoinositides in GH4C1 cells. J Pharmacol Exp Ther 271:238-245
- (1994) J Pharmacol Exp Ther , vol.271 , pp. 238-245
- Friedman, Z.Y.¹

6
- 0023129529
- Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cell line
- Greenberg DA, Carpenter CL, Messing RO (1987) Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cell line. Cancer Res 47:70-74
- (1987) Cancer Res , vol.47 , pp. 70-74
- Greenberg, D.A.¹ Carpenter, C.L.² Messing, R.O.³

7
- 0032906119
- Clinical pharmacology of selective estrogen receptor modulators
- Haynes B, Dowsett M (1999) Clinical pharmacology of selective estrogen receptor modulators. Drugs Aging 14:323-336
- (1999) Drugs Aging , vol.14 , pp. 323-336
- Haynes, B.¹ Dowsett, M.²

8
- 0030981833
- i in human breast cancer cells
- i in human breast cancer cells. Anticancer Res 17:1167-1174
- (1997) Anticancer Res , vol.17 , pp. 1167-1174
- Jain, P.T.¹ Trump, B.F.²

9
- 0034306059
- 2+ and cytotoxicity in intact cells
- 2+ and cytotoxicity in intact cells. Toxicol Appl Pharmacol 168:58-63
- (2000) Toxicol Appl Pharmacol , vol.168 , pp. 58-63
- Jan, C.R.¹ Cheng, J.S.² Chou, K.J.³ Wang, S.P.⁴ Lee, K.C.⁵ Tang, K.Y.⁶ Tseng, L.L.⁷ Chiang, H.T.⁸

10
- 0034105135
- 2+ in bladder female transitional carcinoma (BFTC) cells
- 2+ in bladder female transitional carcinoma (BFTC) cells. Chin J Physiol 43:29-33
- (2000) Chin J Physiol , vol.43 , pp. 29-33
- Jan, C.R.¹ Yu, C.C.² Huang, J.K.³

11
- 0033288336
- Mitochondrial control of apoptosis: An overview
- Kroemer G (1999) Mitochondrial control of apoptosis: an overview. Biochem Soc Symp 66:1-15
- (1999) Biochem Soc Symp , vol.66 , pp. 1-15
- Kroemer, G.¹

12
- 0021321610
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase
- Lam HY (1984) Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem Biophys Res Commun 118:27-32
- (1984) Biochem Biophys Res Commun , vol.118 , pp. 27-32
- Lam, H.Y.¹

13
- 0028144440
- Effect of tamoxifen on carbachol-triggered intracellular calcium responses in chicken granulosa cells
- Morley P, Whitfield JF (1994) Effect of tamoxifen on carbachol-triggered intracellular calcium responses in chicken granulosa cells. Cancer Res 54:69-74
- (1994) Cancer Res , vol.54 , pp. 69-74
- Morley, P.¹ Whitfield, J.F.²

14
- 0030071752
- Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: A potential use in intravesical chemotherapy
- Pu YS, Hsieh TS, Cheng AL, Tseng NF, Su IJ, Hsieh CY, Lai MK, Tsai TC (1996) Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy. Br J Urol 77:76-85
- (1996) Br J Urol , vol.77 , pp. 76-85
- Pu, Y.S.¹ Hsieh, T.S.² Cheng, A.L.³ Tseng, N.F.⁴ Su, I.J.⁵ Hsieh, C.Y.⁶ Lai, M.K.⁷ Tsai, T.C.⁸

15
- 0022575011
- A model for receptor-regulated calcium entry
- Putney JW Jr (1986) A model for receptor-regulated calcium entry. Cell Calcium 7:1-12
- (1986) Cell Calcium , vol.7 , pp. 1-12
- Putney J.W., Jr.¹

16
- 0023677804
- Tamoxifen reduces calcium currents in a clonal pituitary cell line
- Sartor P, Vacher P, Mollard P, Dufy B (1988) Tamoxifen reduces calcium currents in a clonal pituitary cell line. Endocrinology 123:534-540
- (1988) Endocrinology , vol.123 , pp. 534-540
- Sartor, P.¹ Vacher, P.² Mollard, P.³ Dufy, B.⁴

17
- 0030439246
- Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats
- Song J, Standley PR, Zhang F, Joshi D, Gappy S, Sowers JR, Ram JL (1996) Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J Pharmacol Exp Ther 277:1444-1453
- (1996) J Pharmacol Exp Ther , vol.277 , pp. 1444-1453
- Song, J.¹ Standley, P.R.² Zhang, F.³ Joshi, D.⁴ Gappy, S.⁵ Sowers, J.R.⁶ Ram, J.L.⁷

18
- 0025332577
- 2+-ATPase
- 2+-ATPase. Proc Natl Acad Sci USA 87:2466-2470
- (1990) Proc Natl Acad Sci USA , vol.87 , pp. 2466-2470
- Thastrup, O.¹ Cullen, P.T.² Drobak, B.K.³ Hanley, M.R.⁴ Dawson, A.P.⁵

19
- 0026327816
- The aminosteroid U73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells
- Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK (1991) The aminosteroid U73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. J Biol Chem 266:23856-23862
- (1991) J Biol Chem , vol.266 , pp. 23856-23862
- Thompson, A.K.¹ Mostafapour, S.P.² Denlinger, L.C.³ Bleasdale, J.E.⁴ Fisher, S.K.⁵

20
- 0032992254
- Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogs
- Waddle JR, Fine RL, Case BC, Trogdon ML, Tyczkowska K, Frazier D, Page RL (1999) Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogs. Cancer Chemother Pharmacol 44: 74-80
- (1999) Cancer Chemother Pharmacol , vol.44 , pp. 74-80
- Waddle, J.R.¹ Fine, R.L.² Case, B.C.³ Trogdon, M.L.⁴ Tyczkowska, K.⁵ Frazier, D.⁶ Page, R.L.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.